Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials and compliance.
CIN U74999KA2019PLC127964 Incorporated 16 September 2019 ROC Bangalore HQ Bangalore, Karnataka, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹644.99 Cr
▲ 44.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹170 Cr
Registered with MCA
Paid-up capital
₹156.12 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
906
Latest available

About Aurigene Pharmaceutical Services Limited

Data last updated: 06 January 2026

Aurigene Pharmaceutical Services Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited). It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 16 September 2019, the company has been in operation for over 7 years.

Registered with ROC Bangalore under CIN U74999KA2019PLC127964.

Capital: an authorised share capital of ₹170 Cr and a paid-up capital of ₹156.12 Cr. It is led by directors including Erez Israeli and Deepak Sapra.

Last AGM: 16 July 2025. Financial statements filed for year ended 31 March 2025. Office: 39 – 40 Kiadb Industrial Area Electronic City Phase Ii Hosur Road, Bangalore, Karnataka, India – 560100.

As per the financials filed for FY 2025, the company reported a revenue of ₹644.99 Cr, a growth of 44% compared to the previous year.

The company has a workforce of approximately 906 employees as per the latest available data. It operates as a subsidiary of Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited).

The company is associated with 1 brand - Aurigene Pharmaceutical.

For more details, the company can be reached via its website aurigeneservices.com.

Company Details of Aurigene Pharmaceutical Services Limited
CIN U74999KA2019PLC127964
Registration Number 127964
Incorporation Date 16 September 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 16 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited)
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    39 – 40 Kiadb Industrial Area Electronic City Phase Ii Hosur Road, Bangalore, Karnataka, India – 560100
  • Industry
    Pharma, Pharma Contract R&D
Company report
Aurigene Pharmaceutical Services Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Aurigene Pharmaceutical Services Limited report

Financials, compliance, directors, charges, ownership and filings for Aurigene Pharmaceutical Services Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited operates one associated brand: Aurigene Pharmaceutical. These brands represent Aurigene Pharmaceutical Services Limited's diversified market presence and brand portfolio.

Brand Description Website
Provides integrated CRO and CDMO services for drug discovery and manufacturing. aurigeneservices.com

Competitors & Alternatives of Aurigene Pharmaceutical Services Limited

Brands and companies operating in the same space as Aurigene Pharmaceutical Services Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.

Competitor Description Location Founded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO. Ahmedabad, India, India 2000
BDR Pharmaceuticals Internationals BDR Pharmaceuticals Internationals APIs and finished products are developed and manufactured. Mumbai, India, India 2003
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered. Craigavon, United Kingdom, United Kingdom 2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments. Mumbai, India, India 1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO. Hunt Valley, United States, United States 1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications. Hyderabad, India, India 1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided. Ecully, France, France 2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem. Morrisville, United States, United States 1995
Aptuit Aptuit Contract research and development services for small molecules are offered. Greenwich, United States, United States 2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development Woburn, United States, United States 2012

Business Activity of Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Aurigene Pharmaceutical Services Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited is audited by S.R. Batliboi & Associates LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S.R. Batliboi & Associates LLP Locked Locked Locked
Premium access

Complete auditor history for Aurigene Pharmaceutical Services Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited currently reports 4 directors and 2 key managerial personnel. 6 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Erez Israeli Director 16 Sep 2019 6 Years 10 Months Current
Deepak Sapra Director 16 Sep 2019 6 Years 10 Months Current
Mannam Venkata Narasimham Director 16 Sep 2019 6 Years 10 Months Current
Atul Sachdeva Cfo 27 Jul 2022 4 Years 0 Months Current
Sapna Company Secretary 14 Nov 2024 1 Years 8 Months Current
Jesal Agarwal Director 29 Mar 2024 2 Years 3 Months Current

Financials of Aurigene Pharmaceutical Services Limited FY 2025 filings available

Aurigene Pharmaceutical Services Limited reported revenue of ₹644.99 Cr (up 44.00% YoY) for FY 2025.

Revenue · FY 2025
₹644.99 Cr ▲ 44.00%
Premium access

Ten-year financial statements for Aurigene Pharmaceutical Services Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Aurigene Pharmaceutical Services Limited

Premium access

Shareholding and ownership data for Aurigene Pharmaceutical Services Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited has a workforce of 906 employees as of Apr 06, 2024.

Employee count
906
Active EPFO establishments
1
Employee growth
11.71%
Premium access

Employee and EPFO history for Aurigene Pharmaceutical Services Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Aurigene Pharmaceutical Services Limited

Premium access

GST registrations and filing compliance for Aurigene Pharmaceutical Services Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Aurigene Pharmaceutical Services Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Aurigene Pharmaceutical Services Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aurigene Pharmaceutical Services Limited

Premium access

MSME payment history for Aurigene Pharmaceutical Services Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aurigene Pharmaceutical Services Limited

Premium access

Corporate group structure for Aurigene Pharmaceutical Services Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aurigene Pharmaceutical Services Limited

Premium access

MCA filings and documents for Aurigene Pharmaceutical Services Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Aurigene Pharmaceutical Services Limited

Activity
16 Jul 2025
Aurigene Pharmaceutical Services Limited last Annual general meeting of members was held on 16 Jul 2025 as per latest MCA records.
Activity
31 Mar 2025
Aurigene Pharmaceutical Services Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Directors
14 Nov 2024
Sapna was appointed as a Company Secretary on 14 Nov 2024 & has been associated with this company since 1 year 8 months.
Directors
29 Mar 2024
Jesal Agarwal was appointed as a Director on 29 Mar 2024 & has been associated with this company since 2 years 4 months.
Directors
27 Jul 2022
Atul Sachdeva was appointed as a CFO on 27 Jul 2022 & has been associated with this company since 4 years 1 day.
Directors
01 Feb 2022
Akhil Ravi was appointed as a CEO on 01 Feb 2022 & has been associated with this company since 4 years 5 months.

Recent News on Aurigene Pharmaceutical Services Limited

Frequently Asked Questions about Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited is an active public limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 16 September 2019 (7+ years old) and is registered under CIN U74999KA2019PLC127964. The company has 906 employees.

Aurigene Pharmaceutical Services Limited reported revenue of ₹644.99 Cr for FY 2025 (up 44.00% YoY).

The current directors and KMP of Aurigene Pharmaceutical Services Limited are:

The primary industry of Aurigene Pharmaceutical Services Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Aurigene Pharmaceutical Services Limited can be reached at the registered office: 39 – 40 Kiadb Industrial Area Electronic City Phase Ii Hosur Road, Bangalore, Karnataka, India – 560100, or through the website aurigeneservices.com.

The authorised capital is ₹170 Cr, and the paid-up capital is ₹156.12 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available